TW
GILD icon

TritonPoint Wealth’s Gilead Sciences GILD Stock Holding History

TritonPoint Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$258K Sell
2,045
-352
-15% -$46.4K 0.03% 255
2026
Q1 		$334K Buy
2,397
+15
+0.6% +$2.1K 0.04% 211
2025
Q4 		$292K Sell
2,382
-4,679
-66% -$569K 0.03% 220
2025
Q3 		$784K Buy
7,061
+145
+2% +$16.5K 0.07% 177
2025
Q2 		$767K Buy
6,916
+243
+4% +$25.9K 0.07% 177
2025
Q1 		$748K Buy
6,673
+407
+6% +$42K 0.07% 178
2024
Q4 		$579K Buy
6,266
+381
+6% +$34.3K 0.05% 192
2024
Q3 		$492K Sell
5,885
-361
-6% -$27.5K 0.05% 210
2024
Q2 		$429K Sell
6,246
-1,631
-21% -$109K 0.04% 219
2024
Q1 		$681K Sell
7,877
-702
-8% -$54K 0.07% 170
2023
Q4 		$695K Buy
+8,579
New +$668K 0.07% 178

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TritonPoint Wealth's GILD Position: Q2 2026 in Review

TritonPoint Wealth reduced its Gilead Sciences (GILD) stake by 15% in Q2 2026, selling an estimated $46.4K and leaving 2,045 shares worth $258K. The position accounts for 0.03% of the portfolio, ranked #255.

TritonPoint Wealth first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $784K in Q3 2025. 2,287 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • TritonPoint Wealth held 2,045 shares of Gilead Sciences worth $258K as of Q2 2026.
  • TritonPoint Wealth sold 352 Gilead Sciences shares in Q2 2026, an estimated $46.4K.
  • Gilead Sciences made up 0.03% of TritonPoint Wealth's portfolio in Q2 2026, its #255 holding.
  • TritonPoint Wealth first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • TritonPoint Wealth's Gilead Sciences position peaked at $784K in Q3 2025.
  • 2,287 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on TritonPoint Wealth's 13F filing for Q2 2026, filed 11 Aug 2026.